Swiss Entertainment Stock News

Valiant Holding AG reported first-quarter 2026 results with net interest income of CHF 100.64 million and net income of CHF 33.24 million, both slightly higher than a year earlier. Despite this modest improvement, investors focused on the bank’s elevated debt levels and challenging revenue trends, which raised concerns about its financial flexibility and resilience. We’ll now examine how these weaker-than-expected earnings, alongside concerns over the high debt-to-equity ratio, shape Valiant...

Why Kuros Biosciences (SWX:KURN) is on investors’ radar today Kuros Biosciences (SWX:KURN) has drawn attention after recent share price pressure, with the stock showing a 15.1% decline over the past month and a 20.2% decline over the past 3 months. See our latest analysis for Kuros Biosciences. At the latest share price of CHF20.12, Kuros Biosciences shows weaker short term momentum, with a 1 month share price return of 15.1% decline and a year to date share price return of 24.6% decline,...

Novartis has started construction on a new radioligand therapy manufacturing facility in Denton, Texas. The Denton site expands the company’s US network for advanced cancer treatments and is part of a broader multi year, multi billion dollar US investment plan. The project is expected to support access to personalized cancer therapies and create jobs in bioengineering and advanced manufacturing. For investors following Novartis (SWX:NOVN), the Denton build out comes as the stock trades...

If you are asking whether UBS Group is priced attractively right now, the starting point is to look closely at what the current share price might already be assuming. The stock last closed at CHF 35.03, with returns of 1.5% over 7 days, 8.1% over 30 days, a 8.2% decline year to date, and gains of 38.4% over 1 year, 120.8% over 3 years and 189.1% over 5 years. Recent headlines have focused on UBS Group's role as a major global banking and wealth management group, including its ongoing...

Roche Holding (SWX:ROP) has entered a definitive agreement to acquire PathAI, a US-based provider of digital pathology and AI-powered diagnostic technologies. The deal is intended to expand Roche's digital pathology offering and support AI-driven diagnostics and precision oncology. The acquisition also aims to support biopharma partners with AI-enabled services in clinical trials and translational research. For Roche, which operates across pharmaceuticals and diagnostics, the PathAI deal...

If you are wondering whether Temenos is priced fairly or if the current share price leaves room for upside, it helps to start by looking closely at what the market has been paying for this stock recently. Temenos shares recently closed at CHF 74.20, with returns of 0.4% over 7 days, 2.3% over 30 days, a 9.0% decline year to date, and 22.6% over the past year. Together, these figures present a mixed picture of changing expectations and risk perception. Recent coverage of Temenos has focused...

If you are wondering whether Alcon at around $49.17 is starting to look like value after a tough spell, this breakdown will help you frame the opportunity and the risks. The stock has faced sharp share price pressure, with returns of a 15.5% decline over 7 days, a 19.7% decline over 30 days, a 22.6% decline year to date and a 37.9% decline over 1 year, as well as a 29.9% decline over 3 years and a 19.2% decline over 5 years. Recent coverage has focused on how this sustained weakness has put...

Vaudoise Assurances Holding SA ( VTX:VAHN ) is about to trade ex-dividend in the next 3 days. The ex-dividend date is...

The investors in ams-OSRAM AG 's ( VTX:AMS ) will be rubbing their hands together with glee today, after the share...

Swiss Re (SWX:SREN) has wrapped up FY 2025 with fourth quarter revenue of US$10.6b and basic EPS of US$2.43, capping a trailing twelve month EPS of US$15.67 on total revenue of US$42.6b. Over recent quarters the company has seen revenue in a tight band between US$10.5b and US$11.0b, while quarterly EPS ranged from US$0.35 in Q3 2024 to US$4.85 in Q3 2025, giving investors a clear view of how earnings have tracked through the year. With net profit margins over the last twelve months at 10.8%...

ABB is expanding its role in digital twin technology for the marine industry, focusing on real time optimization and asset monitoring. The company is deepening its digital solutions offering for ship operators, adding to its traditional electrification and automation capabilities. This move highlights ABB's push into asset lifecycle management within a growing segment of the maritime market. For investors tracking SWX:ABBN, this push into marine digital twins sits alongside a share price of...

OC Oerlikon Corporation AG recently completed a CHF 200 million senior unsecured fixed-rate bond issuance carrying a 2.125% coupon and maturing in May 2031. This new bond reshapes the group’s funding mix and liquidity position, which may influence how investors assess its balance sheet strength and flexibility. We’ll now examine how this CHF 200 million senior unsecured bond issue may alter OC Oerlikon’s existing investment narrative and outlook. The best AI stocks today may lie beyond...

Adecco Group (SWX:ADEN) is back in focus after finalizing its 2025 scrip dividend, with 53.01% of shareholders choosing new shares and 5,268,324 shares issued alongside the cash payout on 7 May 2026. See our latest analysis for Adecco Group. Even with the scrip dividend in place, Adecco Group's share price at CHF18.27 reflects weak momentum. The 90 day share price return is 20.36%, and the 1 year total shareholder return shows a 16.87% decline, suggesting sentiment has softened despite the...

As the European market navigates a landscape marked by stalled geopolitical negotiations and fluctuating oil prices, the pan-European STOXX Europe 600 Index has remained relatively stable, reflecting cautious investor sentiment amid ongoing economic uncertainties. Against this backdrop, growth companies with high insider ownership can offer unique insights into potential investment opportunities, as insider stakes often signal confidence in a company's long-term prospects despite broader...

UBS Group is signaling interest in expanding in the US through acquisitions following its integration of Credit Suisse. Leadership is highlighting growth ambitions in the Americas and pointing to recent inflows of new client assets in the region. The group has received a national US banking license and announced executive hires in key US regions to support potential expansion. UBS Group (SWX:UBSG) is trading around CHF34.94, with the stock up 39.1% over the past year and 190.3% over five...

It looks like Zuger Kantonalbank ( VTX:ZUGER ) is about to go ex-dividend in the next 3 days. Typically, the...

Investors in Logitech International S.A. ( VTX:LOGN ) had a good week, as its shares rose 6.6% to close at CHF81.82...

As you might know, Geberit AG ( VTX:GEBN ) recently reported its quarterly numbers. Geberit reported in line with...

ams-OSRAM (SWX:AMS) has opened 2026 with Q1 revenue of €796 million and a basic EPS loss of €1.57, alongside a net income loss of €155 million, putting fresh numbers behind a story that already had investors watching closely. Over recent quarters the company has seen revenue move between €775 million and €881 million, while quarterly EPS has ranged from a small €0.01 profit to losses of €0.83. This gives you a clear view of how top line stability contrasts with pressure on the bottom line...

Q1 2026 earnings snapshot Swisscom (SWX:SCMN) kicked off 2026 with Q1 revenue of CHF3.6b and basic EPS of CHF6.41, alongside net income of CHF332m, providing an early indication of how the year is starting to develop. Over recent quarters, revenue has moved between CHF2.9b in Q4 2024 and CHF3.9b in Q4 2025, while quarterly EPS has ranged from about CHF5.00 to CHF7.08, giving investors a view of how the top and bottom lines have been tracking ahead of this latest report. With trailing net...

Earnings miss, weaker profit, and new buyback sharpen focus on Alcon stock Alcon (SWX:ALC) reported first quarter 2026 revenue growth supported by recent product launches and market share gains. Profit came under pressure, guidance was reaffirmed, and a US$1.5b share repurchase plan was introduced. See our latest analysis for Alcon. Alcon's latest earnings and the new US$1.5b buyback have coincided with a sharp reset in sentiment, with a 7 day share price return of a 13.6% decline and a 1...

Novartis (SWX:NOVN) just picked up European Commission approval for Rhapsido, a first in class oral treatment for chronic spontaneous urticaria, while also committing substantial US manufacturing and research spending on advanced therapies. See our latest analysis for Novartis. Recent news around Rhapsido approval and expanded US manufacturing sits against a share price of CHF115.64, with a 1 year total shareholder return of 29.77% and a 5 year total shareholder return of 83.35%. This...

Bucher Industries (SWX:BUCN) has drawn fresh attention after issuing 2026 guidance, signalling expectations for stable sales and an operating margin in line with last year, while highlighting political uncertainty around demand recovery. See our latest analysis for Bucher Industries. The share price has reacted positively to the new 2026 guidance in the very short term, with a 1 day share price return of 2.24% and a 7 day share price return of 4.25%. However, this comes against a weaker...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...